BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7850554)

  • 1. Subtotal splenectomy preserving the inferior splenic pole for the treatment of Hodgkin's lymphoma.
    Petroianu A
    Int J Surg Case Rep; 2017; 36():1-3. PubMed ID: 28486174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term complications of laparotomy in Hodgkin's disease.
    Jockovich M; Mendenhall NP; Sombeck MD; Talbert JL; Copeland EM; Bland KI
    Ann Surg; 1994 Jun; 219(6):615-21; discussion 621-4. PubMed ID: 8203970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease.
    Andrieu JM; Ifrah N; Payen C; Fermanian J; Coscas Y; Flandrin G
    J Clin Oncol; 1990 Jul; 8(7):1148-54. PubMed ID: 2193118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial splenectomy in children: an alternative for splenectomy in the pathological staging of Hodgkin's disease.
    Hoekstra HJ; Tamminga RY; Timens W
    Ann Surg Oncol; 1994 Nov; 1(6):480-6. PubMed ID: 7850554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology.
    Oberlin O; Leverger G; Pacquement H; Raquin MA; Chompret A; Habrand JL; Terrier-Lacombe MJ; Bey P; Bertrand Y; Rubie H
    J Clin Oncol; 1992 Oct; 10(10):1602-8. PubMed ID: 1383434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Hodgkin's disease in children with alternating mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) and adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) courses without radiotherapy.
    van den Berg H; Stuve W; Behrendt H
    Med Pediatr Oncol; 1997 Jul; 29(1):23-7. PubMed ID: 9142201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laparotomy and splenectomy in Hodgkin's disease: a reappraisal after twenty years.
    Rosenberg SA
    Scand J Haematol; 1985 Apr; 34(4):289-92. PubMed ID: 2408324
    [No Abstract]   [Full Text] [Related]  

  • 9. Thymus-independent antigens: complexity of B-lymphocyte activation revealed.
    Mosier DE; Subbarao B
    Immunol Today; 1982 Aug; 3(8):217-22. PubMed ID: 25289853
    [No Abstract]   [Full Text] [Related]  

  • 10. Splenic studies. I. Susceptibility to infection after splenectomy performed in infancy.
    KING H; SHUMACKER HB
    Ann Surg; 1952 Aug; 136(2):239-42. PubMed ID: 14953147
    [No Abstract]   [Full Text] [Related]  

  • 11. Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease.
    Tura S; Fiacchini M; Zinzani PL; Brusamolino E; Gobbi PG
    J Clin Oncol; 1993 May; 11(5):925-30. PubMed ID: 8487056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Partial instead of complete splenectomy in children for the pathological staging of Hodgkin disease].
    Hoekstra HJ; Tamminga RY; Timens W
    Ned Tijdschr Geneeskd; 1993 Nov; 137(48):2491-4. PubMed ID: 8272125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of stages I to III Hodgkin disease in children.
    Dearth JC; Gilchrist GS; Burgert EO; Telander RL; Cupps RE
    J Pediatr; 1980 May; 96(5):829-36. PubMed ID: 7365581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host defense against Streptococcus pneumoniae: the role of the spleen.
    Wara DW
    Rev Infect Dis; 1981; 3(2):299-309. PubMed ID: 7256088
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.